{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["5-Fluorouracil", "Apoptosis", "Gastric cancer", "Lupeol"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26892272", "DateCompleted": {"Year": "2017", "Month": "01", "Day": "09"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "02", "Day": "19"}], "ELocationID": ["10.1007/s00210-016-1221-y"], "Language": ["eng"], "Journal": {"ISSN": "1432-1912", "JournalIssue": {"Volume": "389", "Issue": "5", "PubDate": {"Year": "2016", "Month": "May"}}, "Title": "Naunyn-Schmiedeberg's archives of pharmacology", "ISOAbbreviation": "Naunyn Schmiedebergs Arch Pharmacol"}, "ArticleTitle": "Lupeol enhances inhibitory effect of 5-fluorouracil on human gastric carcinoma cells.", "Pagination": {"StartPage": "477", "EndPage": "484", "MedlinePgn": "477-84"}, "Abstract": {"AbstractText": ["Lupeol, a dietary triterpene present in many fruits and medicinal plants, has been reported to possess many pharmacological properties including cancer-preventive and anti-cancer effects in vitro and in vivo. Here, we investigated the anti-cancer efficacy and adjuvant chemotherapy action of lupeol in gastric cancer (GC) cells (SGC7901 and BGC823) and explored the underlying mechanisms. Cells were treated with lupeol and/or 5-fluorouracil (5-Fu) and subjected to cell viability, colony formation, apoptosis, western blot, semiquantitative RT-PCR, and xenograft tumorigenicity assay. Our results showed that lupeol and 5-Fu inhibited the proliferation of SGC7901 and BGC823 cells, and combination treatment with lupeol and 5-Fu resulted in a combination index < 1, indicating a synergistic effect. Co-treatment with lupeol and 5-Fu induced apoptosis through up-regulating the expressions of Bax and p53 and down-regulating the expressions of survivin and Bcl-2. Furthermore, co-treatment displayed more efficient inhibition of tumor weight and volume on BGC823 xenograft mouse model than single-agent treatment with 5-Fu or lupeol. Taken together, our findings highlight that lupeol sensitizes GC to 5-Fu treatment, and combination treatment with lupeol and 5-Fu would be a promising therapeutic strategy for human GC treatment."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Wujiang No. 1 People's Hospital, Suzhou, 215200, China."}], "LastName": "Liu", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Geriatric Ward, Wujiang No. 1 People's Hospital, Suzhou, 215200, China."}], "LastName": "Bi", "ForeName": "Tingting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Wujiang No. 1 People's Hospital, Suzhou, 215200, China."}], "LastName": "Dai", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Wujiang No. 1 People's Hospital, Suzhou, 215200, China."}], "LastName": "Wang", "ForeName": "Gang", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Wujiang No. 1 People's Hospital, Suzhou, 215200, China."}], "LastName": "Qian", "ForeName": "Liqiang", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Wujiang No. 1 People's Hospital, Suzhou, 215200, China."}], "LastName": "Shen", "ForeName": "Genhai", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Wujiang No. 1 People's Hospital, Suzhou, 215200, China. wjyygqg@sohu.com."}], "LastName": "Gao", "ForeName": "Quangen", "Initials": "Q"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Retracted Publication"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Naunyn Schmiedebergs Arch Pharmacol", "NlmUniqueID": "0326264", "ISSNLinking": "0028-1298"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antimetabolites, Antineoplastic"}, {"RegistryNumber": "0", "NameOfSubstance": "Pentacyclic Triterpenes"}, {"RegistryNumber": "O268W13H3O", "NameOfSubstance": "lupeol"}, {"RegistryNumber": "U3P01618RT", "NameOfSubstance": "Fluorouracil"}], "CommentsCorrectionsList": [{"RefSource": "Naunyn Schmiedebergs Arch Pharmacol. 2021 Oct;394(10):2145. doi: 10.1007/s00210-021-02141-y", "PMID": "34386840"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antimetabolites, Antineoplastic"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Fluorouracil"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Pentacyclic Triterpenes"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Stomach Neoplasms"}, {"QualifierName": [], "DescriptorName": "Xenograft Model Antitumor Assays"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Curr Mol Pharmacol. 2008 Nov;1(3):244-54", "ArticleIdList": ["20021437"]}, {"Citation": "World J Gastroenterol. 2007 Mar 28;13(12):1788-93", "ArticleIdList": ["17465467"]}, {"Citation": "Clin Cancer Res. 2008 Aug 15;14(16):5000-5", "ArticleIdList": ["18698017"]}, {"Citation": "Ann Oncol. 2008 Jul;19 Suppl 5:v103-7", "ArticleIdList": ["18611865"]}, {"Citation": "Biochem Soc Symp. 2006;(73):181-9", "ArticleIdList": ["16626298"]}, {"Citation": "Nat Rev Cancer. 2009 Jul;9(7):501-7", "ArticleIdList": ["19550425"]}, {"Citation": "Cytotechnology. 2016 Jan;68(1):123-133", "ArticleIdList": ["25037728"]}, {"Citation": "Curr Opin Cell Biol. 2006 Dec;18(6):609-15", "ArticleIdList": ["16934447"]}, {"Citation": "Cancer Lett. 2009 Nov 28;285(2):109-15", "ArticleIdList": ["19464787"]}, {"Citation": "Naunyn Schmiedebergs Arch Pharmacol. 2015 Mar;388(3):295-304", "ArticleIdList": ["25418891"]}, {"Citation": "Oncol Rep. 2010 Jun;23(6):1735-45", "ArticleIdList": ["20428833"]}, {"Citation": "CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29", "ArticleIdList": ["22237781"]}, {"Citation": "PLoS One. 2015 Sep 14;10(9):e0137888", "ArticleIdList": ["26368019"]}, {"Citation": "PLoS One. 2013;8(2):e57218", "ArticleIdList": ["23451189"]}, {"Citation": "Phytother Res. 2003 Apr;17(4):341-4", "ArticleIdList": ["12722136"]}, {"Citation": "Cell Physiol Biochem. 2011;28(2):219-28", "ArticleIdList": ["21865729"]}, {"Citation": "Cancer Cell Int. 2013 Nov 01;13(1):108", "ArticleIdList": ["24176221"]}, {"Citation": "Tumour Biol. 2016 Jun;37(6):7589-97", "ArticleIdList": ["26687645"]}, {"Citation": "Nat Rev Cancer. 2003 May;3(5):330-8", "ArticleIdList": ["12724731"]}, {"Citation": "Pak J Pharm Sci. 2007 Apr;20(2):125-7", "ArticleIdList": ["17416567"]}, {"Citation": "Cancer Lett. 2008 May 8;263(1):1-13", "ArticleIdList": ["18359153"]}, {"Citation": "Technol Cancer Res Treat. 2016 Dec;15(6):NP16-NP24", "ArticleIdList": ["26443801"]}, {"Citation": "Technol Cancer Res Treat. 2016 Jun;15(3):487-97", "ArticleIdList": ["26009496"]}, {"Citation": "Cancer Res. 2010 Jan 15;70(2):440-6", "ArticleIdList": ["20068163"]}, {"Citation": "Food Chem Toxicol. 2010 Mar;48(3):807-13", "ArticleIdList": ["20034537"]}, {"Citation": "J Pathol. 1999 Jan;187(1):112-26", "ArticleIdList": ["10341712"]}, {"Citation": "Stem Cells. 2007 Jan;25(1):149-55", "ArticleIdList": ["17008426"]}, {"Citation": "Carcinogenesis. 2009 May;30(5):808-17", "ArticleIdList": ["19233958"]}, {"Citation": "Int J Hematol. 2004 Oct;80(3):205-9", "ArticleIdList": ["15540893"]}, {"Citation": "Biosci Biotechnol Biochem. 2012;76(1):183-5", "ArticleIdList": ["22232260"]}, {"Citation": "Carcinogenesis. 2010 Oct;31(10):1844-53", "ArticleIdList": ["20732907"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "1", "Day": "17"}, {"Year": "2016", "Month": "2", "Day": "9"}, {"Year": "2016", "Month": "2", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "2", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "10", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26892272", "10.1007/s00210-016-1221-y", "10.1007/s00210-016-1221-y"]}}], "PubmedBookArticle": []}